Ilustración: Pablo Garcia Guión: Rogelio Román
No se si se hará la misma "reflexión" la industria farmaceutica trasnacional si se cumplen las previsiones que dicen :
Obama's plans include controlling prices on expensive biotech drugs, plans to regulate DTC advertising and a push toward generics. While lobbyists have thus far been successful in keeping DTC regulations at by, with a strong democratic presence, their success might be limited. Likewise, generic options, re-importation and greater price controls might be on the horizon.
No hay comentarios:
Publicar un comentario